DPP4 and breast cancer: Further analysis revealed that when recombinant DPP4 was co-incubated directly with breast cancer cells and subsequently analyzed by flow cytometry using an anti-ICOSL antibody, the level of mICOSL remained unaffected by the concentration of DPP4 (Figure S3A).